Apple Inc. litigation

Apple Announces New Today at Apple Sessions

Retrieved on: 
Tuesday, January 29, 2019

Apple today announced a new Today at Apple release with sessions in three new and expanded formats Skills, Walks and Labs which offer hands-on group sessions focused on photography, video, music, coding, app development, art and design and more.

Key Points: 
  • Apple today announced a new Today at Apple release with sessions in three new and expanded formats Skills, Walks and Labs which offer hands-on group sessions focused on photography, video, music, coding, app development, art and design and more.
  • Since the launch of Today at Apple in 2017, Apple has held over 18,000 free sessions a week attended by millions of participants around the world.
  • To further enrich the Today at Apple experience in every store, Apple is upgrading the existing fleet of stores with design elements that greatly increase the stores Today at Apple sessions and capacity.
  • Apple, Apple Store, Today at Apple and the Apple logo are trademarks of Apple Inc. Other company and product names may be trademarks of their respective owners.

RegenLab Dismisses All Patent Infringement Claims Against Eclipse's Customers

Retrieved on: 
Tuesday, December 11, 2018

DALLAS, Dec. 11, 2018 /PRNewswire/ --On November 29, 2018, RegenLab USA, LLC filed a Notice with the United States District Court for the Southern District of New York to dismiss its patent infringement claims against all of the remaining customers of Eclipse MedCorp, LLC.

Key Points: 
  • DALLAS, Dec. 11, 2018 /PRNewswire/ --On November 29, 2018, RegenLab USA, LLC filed a Notice with the United States District Court for the Southern District of New York to dismiss its patent infringement claims against all of the remaining customers of Eclipse MedCorp, LLC.
  • In a corresponding press release from RegenLab USA, LLC, RegenLab stated that it "dismissed its suit against Eclipse's customers in order to focus on Eclipse."
  • RegenLab recently lost its patent infringement lawsuits in Germany; and, RegenLab lost a nearly identical preliminary patent infringement lawsuit in the European Union, which RegenLab was forced to appeal (appellate hearing pending).
  • RegenLab did not have any evidence that Eclipse or its customers violated RegenLab's patents.

'Back to School' Specials Announced at All Experimac® Stores

Retrieved on: 
Friday, November 30, 2018

Experimac , home to a great range of fully certified pre-owned, quality Apple products and devices, is offering its own "Back to School" version with specials on a limited time inventory.

Key Points: 
  • Experimac , home to a great range of fully certified pre-owned, quality Apple products and devices, is offering its own "Back to School" version with specials on a limited time inventory.
  • The use of the Apple Inc. logo or trademark does not represent an endorsement by Apple Inc. of Experimac or United Franchise Group.
  • Your Local Experimac can also repair, upgrade or buy your current device, and no appointment is ever necessary.
  • Today, there are more than 100 locations across the globe; Experimac stores can be found in Australia, Mexico, Chile, South Africa, France, Canada, Uruguay and Ireland.

'Back to School' Specials Announced at All Experimac® Stores

Retrieved on: 
Friday, November 30, 2018

Experimac , home to a great range of fully certified pre-owned, quality Apple products and devices, is offering its own "Back to School" version with specials on a limited time inventory.

Key Points: 
  • Experimac , home to a great range of fully certified pre-owned, quality Apple products and devices, is offering its own "Back to School" version with specials on a limited time inventory.
  • The use of the Apple Inc. logo or trademark does not represent an endorsement by Apple Inc. of Experimac or United Franchise Group.
  • Your Local Experimac can also repair, upgrade or buy your current device, and no appointment is ever necessary.
  • Today, there are more than 100 locations across the globe; Experimac stores can be found in Australia, Mexico, Chile, South Africa, France, Canada, Uruguay and Ireland.

Orexo Wins Appeal Against Actavis on Zubsolv Patent in the US

Retrieved on: 
Monday, September 10, 2018

The decision was rendered in the patent litigation alleging that Actavis's generic Zubsolv 1.4/0.36 mg and 5.7/1.4 mg buprenorphine/naloxone products infringe Orexo's US Patent Nos.

Key Points: 
  • The decision was rendered in the patent litigation alleging that Actavis's generic Zubsolv 1.4/0.36 mg and 5.7/1.4 mg buprenorphine/naloxone products infringe Orexo's US Patent Nos.
  • In the November 15, 2016 judgment, the district court held that Orexo's '996 patent is valid and infringed by Actavis, and that Orexo's '330 patent is invalid.
  • The decision on the '996 patent was not appealed and not affected by the decision of the Court of Appeals.
  • Orexo will now request the District Court of Delaware to issue a judgment that Actavis's generic Zubsolv products infringe the '330 patent, and will not be FDA approved until 2032.

Orexo Wins Appeal Against Actavis on Zubsolv Patent in the US

Retrieved on: 
Monday, September 10, 2018

The decision was rendered in the patent litigation alleging that Actavis's generic Zubsolv 1.4/0.36 mg and 5.7/1.4 mg buprenorphine/naloxone products infringe Orexo's US Patent Nos.

Key Points: 
  • The decision was rendered in the patent litigation alleging that Actavis's generic Zubsolv 1.4/0.36 mg and 5.7/1.4 mg buprenorphine/naloxone products infringe Orexo's US Patent Nos.
  • In the November 15, 2016 judgment, the district court held that Orexo's '996 patent is valid and infringed by Actavis, and that Orexo's '330 patent is invalid.
  • The decision on the '996 patent was not appealed and not affected by the decision of the Court of Appeals.
  • Orexo will now request the District Court of Delaware to issue a judgment that Actavis's generic Zubsolv products infringe the '330 patent, and will not be FDA approved until 2032.

RetailMeNot, Inc. Files Patent Infringement Lawsuit Against Honey Science Corp.

Retrieved on: 
Tuesday, June 26, 2018

AUSTIN, Texas, June 25, 2018 /PRNewswire/ --RetailMeNot, Inc. today announced that it has filed a patent infringement lawsuit against Honey Science Corp.

Key Points: 
  • AUSTIN, Texas, June 25, 2018 /PRNewswire/ --RetailMeNot, Inc. today announced that it has filed a patent infringement lawsuit against Honey Science Corp.
  • In the complaint, RetailMeNot alleges that Honey has infringed and continues to infringe four of RetailMeNot's patents, specifically U.S.
  • RetailMeNot's lawsuit therefore seeks both a permanent injunction and damages in an amount to be determined at trial.
  • RetailMeNot, Inc. ( https://www.retailmenot.com/corp/ ) is a leading savings destination connecting consumers with retailers, restaurants, and brands, both online and in-store.

Laidian Technology Wins Patent Infringement Lawsuit Against JMEI's Affiliate Jiedian

Retrieved on: 
Thursday, June 7, 2018

BEIJING, June 7, 2018 /PRNewswire/ -- Laidian Technology has achieved major success in a recent patent infringement lawsuit against Shenzhen Jiedian Technology Co, a wholly owned affiliate ofJMEI, with the court ordering the defendant to stop infringing activities and stop the selling of infringing products within 30 days of the judgment.

Key Points: 
  • BEIJING, June 7, 2018 /PRNewswire/ -- Laidian Technology has achieved major success in a recent patent infringement lawsuit against Shenzhen Jiedian Technology Co, a wholly owned affiliate ofJMEI, with the court ordering the defendant to stop infringing activities and stop the selling of infringing products within 30 days of the judgment.
  • Jiedian was ordered to stop the selling of relevant products that use the patents held by Laidian.
  • The Beijing Intellectual Property Court found two infringements by Jiedian Technology against two patents held by Laidian: Patent No.
  • ZL201520847953.1, a patent for utility models entitled "Mobile Power Bank Rental Equipment and Fixture Device", and Patent No.

3Shape Files US Patent Infringement Complaint Against Align Technology

Retrieved on: 
Wednesday, May 9, 2018

COPENHAGEN, Denmark, May 9, 2018 /PRNewswire-USNewswire/ --3Shape A/S today announced that it has filed a patent infringement complaint asserting its Patent No.

Key Points: 
  • COPENHAGEN, Denmark, May 9, 2018 /PRNewswire-USNewswire/ --3Shape A/S today announced that it has filed a patent infringement complaint asserting its Patent No.
  • US 9,962,244 B2: Focus Scanning Apparatus Recording Color against Align Technology, asserting that Align Technology's ITero Elements intraoral scanner infringes the 3Shape patent.
  • 3Shape filed the complaint in the United States District Court for the District of Delaware alleging patent infringement by Align's iTero Elements intraoral scanner.
  • The district court complaint seeks monetary damages and injunctive relief against further infringement.